Compounds > triazoles
Page last updated: 2024-08-24

triazoles and scopolamine hydrobromide

triazoles has been researched along with scopolamine hydrobromide in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kane, JM; Moran, PM; Moser, PC1
Dudchenko, P; Holley, LA; Sarter, M1
Raffa, RB; Setler, PE; Vaught, JL1
Canas, PM; Cunha, GM; Cunha, RA; Hockemeyer, J; Melo, CS; Müller, CE; Oliveira, CR1
Ballard, TM; Buettelmann, B; Fischer, H; Gasser, R; Hernandez, MC; Knoflach, F; Knust, H; Stadler, H; Thomas, AW; Trube, G1
Almeida, AS; Botton, PH; Chenet, GC; Cunha, RA; Loss, CM; Marques, DM; Mioranzza, S; Nunes, F; Pagnussat, N; Porciúncula, LO1

Other Studies

6 other study(ies) available for triazoles and scopolamine hydrobromide

ArticleYear
Enhancement of working memory performance in the rat by MDL 26,479, a novel compound with activity at the GABAA receptor complex.
    Brain research, 1992, Jan-08, Volume: 569, Issue:1

    Topics: Animals; Antidepressive Agents; Dose-Response Relationship, Drug; Learning; Male; Memory; Rats; Rats, Inbred Strains; Receptors, GABA-A; Reference Values; Reinforcement, Psychology; Scopolamine; Triazoles

1992
Attenuation of muscarinic receptor blockade-induced impairment of spatial delayed alternation performance by the triazole MDL 26,479.
    Psychopharmacology, 1992, Volume: 109, Issue:1-2

    Topics: Animals; Antidepressive Agents; Cognition; Dose-Response Relationship, Drug; Male; Memory, Short-Term; Muscarinic Antagonists; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Scopolamine; Triazoles

1992
The novel anticonvulsant loreclezole (R 72063) does not produce diazepam-like anterograde amnesia in a passive avoidance test in rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 1990, Volume: 342, Issue:5

    Topics: Amnesia; Animals; Anticonvulsants; Avoidance Learning; Diazepam; Male; Rats; Rats, Inbred Strains; Scopolamine; Triazoles

1990
Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801.
    Experimental neurology, 2008, Volume: 210, Issue:2

    Topics: Adenosine A2 Receptor Antagonists; Amyloid beta-Peptides; Analysis of Variance; Animals; Behavior, Animal; Dizocilpine Maleate; Drug Interactions; Male; Maze Learning; Memory Disorders; Motor Activity; Neuroprotective Agents; Peptide Fragments; Purines; Pyrimidines; Rats; Rats, Wistar; Scopolamine; Triazoles

2008
Imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepines as potent and highly selective GABAA alpha5 inverse agonists with potential for the treatment of cognitive dysfunction.
    Bioorganic & medicinal chemistry letters, 2009, Oct-15, Volume: 19, Issue:20

    Topics: Adjuvants, Anesthesia; Animals; Anticonvulsants; Benzodiazepines; Cell Line; Cognition Disorders; Drug Inverse Agonism; GABA-A Receptor Agonists; Humans; Memory, Short-Term; Microsomes, Liver; Rats; Receptors, GABA-A; Scopolamine; Structure-Activity Relationship; Triazoles

2009
Adenosine A(2A) receptors are necessary and sufficient to trigger memory impairment in adult mice.
    British journal of pharmacology, 2015, Volume: 172, Issue:15

    Topics: Adenosine; Animals; Avoidance Learning; Dose-Response Relationship, Drug; Infusions, Intraventricular; Locomotion; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Mice; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrimidines; Receptor, Adenosine A1; Receptor, Adenosine A2A; Recognition, Psychology; Scopolamine; Triazoles; Xanthines

2015